Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma.
Clinical trial NCT01035229 · COMPLETED
Trial details
- NCT number
- NCT01035229
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2013-10-01
- Enrollment
- 546
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.